ConductScience.org, home

Paper458200

Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity.

Takafuji ET and 3 others. J Infect Dis, 1979. Cited by 68 papers, by iCite.

Cite this record

ConductScience Library. Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity. Papers, record 458200. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/458200

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Simultaneous administration of live, enteric-coated adenovirus types 4, 7 and 21 vaccines: safety and immunogenicity.
PubMed
Journal
J Infect Dis
PubMed
Year
1979
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
68
iCite
Relative citation ratio, by iCite
1.75
iCite
Revised in PubMed
2019-05-09
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Takafuji ETE T
2Gaydos JCJ C
3Allen RGR G
4Top FH JrF H

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adenoviruses, HumanMajor topic
Lung DiseasesMajor topic
Viral VaccinesMajor topic
Acute Disease
Antibodies, Viral
Hospitalization
Humans
Male

Source PubMed

Download CSV of topics

Cited by23

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 68 citations.

PMIDTitleJournalYearIn PapersSource
38140619Evolving Horizons: Adenovirus Vectors' Timeless Influence on Cancer, Gene Therapy and Vaccines.Viruses2023https://conductscience.org/library/papers/38140619PubMed
30960873Oral Vaccine Delivery for Intestinal Immunity-Biological Basis, Barriers, Delivery System, and M Cell Targeting.Polymers (Basel)2018https://conductscience.org/library/papers/30960873PubMed
27105067Adenoviral vector-based strategies against infectious disease and cancer.Hum Vaccin Immunother2016https://conductscience.org/library/papers/27105067PubMed
26085551Respiratory Infections in the U.S. Military: Recent Experience and Control.Clin Microbiol Rev2015https://conductscience.org/library/papers/26085551PubMed
23707160Prospects for oral replicating adenovirus-vectored vaccines.Vaccine2013https://conductscience.org/library/papers/23707160PubMed
19079162Distal IgA immunity can be sustained by alphaEbeta7+ B cells in L-selectin-/- mice following oral immunization.Mucosal Immunol2008https://conductscience.org/library/papers/19079162PubMed
17918073Genotype prevalence and risk factors for severe clinical adenovirus infection, United States 2004-2006.Clin Infect Dis2007https://conductscience.org/library/papers/17918073PubMed
16707047Co-infections of adenovirus species in previously vaccinated patients.Emerg Infect Dis2006https://conductscience.org/library/papers/16707047PubMed
16480793Vaccine-preventable adenoviral respiratory illness in US military recruits, 1999-2004.Vaccine2006https://conductscience.org/library/papers/16480793PubMed
16000418
Genomic and bioinformatics analyses of HAdV-4vac and HAdV-7vac, two human adenovirus (HAdV) strains that constituted original prophylaxis against HAdV-related acute respiratory disease, a reemerging epidemic disease.
J Clin Microbiol2005https://conductscience.org/library/papers/16000418PubMed
12885879
Potent, persistent induction and modulation of cellular immune responses in rhesus macaques primed with Ad5hr-simian immunodeficiency virus (SIV) env/rev, gag, and/or nef vaccines and boosted with SIV gp120.
J Virol2003https://conductscience.org/library/papers/12885879PubMed
12522438Selectively replicating viral vectors.Cancer Gene Ther2002https://conductscience.org/library/papers/12522438PubMed
10759404Oncolytic viruses.Invest New Drugs1999https://conductscience.org/library/papers/10759404PubMed
10505113Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.Gene Ther1999https://conductscience.org/library/papers/10505113PubMed
10490767Immune responses to adenovirus and adeno-associated virus in humans.Gene Ther1999https://conductscience.org/library/papers/10490767PubMed
10400771Variability of human systemic humoral immune responses to adenovirus gene transfer vectors administered to different organs.J Virol1999https://conductscience.org/library/papers/10400771PubMed
9457426Use of licensed vaccines for active immunization of the immunocompromised host.Clin Microbiol Rev1998https://conductscience.org/library/papers/9457426PubMed
8764016Structure, function, and evolution of adenovirus-associated RNA: a phylogenetic approach.J Virol1996https://conductscience.org/library/papers/8764016PubMed
8648712Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.J Virol1996https://conductscience.org/library/papers/8648712PubMed
6870545Viral vaccines: the use of currently available products and future developments.Arch Virol1983https://conductscience.org/library/papers/6870545PubMed

See all 23 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/458200

GET https://conductscience.org/api/papers/v1/458200/cited_by?page=2